Controlled trial of enalapril in congestive cardiac failure.

B P McGrath, L Arnolda, P G Matthews, B Jackson, G Jennings, H Kiat, C I Johnston

Twenty five patients with chronic congestive cardiac failure had enalapril (n = 13) or placebo (n = 12) added to their existing regimen of digoxin and frusemide in a randomised double blind trial. Four hours after the first 5 mg dose, the enalapril group showed significant falls in blood pressure, heart rate, and concentrations of plasma angiotensin II, angiotensin converting enzyme, and noradrenaline. During the 12 week trial heart failure became worse in one enalapril treated patient (8%) and in seven placebo treated patients (58%). There were no significant changes in cardiac ejection fraction or exercise duration in either group. Plasma noradrenaline response to graded exercise and maximum exercise rate-pressure product were significantly reduced after four and 12 weeks of active treatment but unchanged with placebo treatment. There was a sustained increase in plasma potassium and a slight rise in plasma creatinine in the enalapril group. Plasma concentrations of the active drug, enalaprilate, were dose related and log enalaprilate correlated significantly with percentage of plasma angiotensin converting enzyme activity (r = -0.66). Enalapril was well tolerated and produced no adverse effects. The drug appears to be superior to placebo and offers considerable promise for the treatment of this condition.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Abdulla, J., Pogue, J., Abildstrom, S. Z., Kober, L., Christensen, E., Pfeffer, M. A., Yusuf, S., Torp-Pedersen, C. (2006). Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction--a meta-analysis. Eur J Heart Fail 8: 90-96 [Abstract] [Full Text]  
• Abdulla, J., Abildstrom, S. Z., Christensen, E., Kober, L., Torp-Pedersen, C. (2004). A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction. Eur J Heart Fail 6: 927-935 [Abstract] [Full Text]  
• Abraham, W. T. (1998). Pharmacologic Management of Chronic Heart Failure: A Review. SEMIN CARDIOTHORAC VASC ANESTH 2: 168-190 [Abstract]  
• The Large State Peer Review Organization Consortiu, (1997). Heart Failure Treatment With Angiotensin-Converting Enzyme Inhibitors in Hospitalized Medicare Patients in 10 Large States. Arch Intern Med 157: 1103-1108 [Abstract]  
• Packer, M., Colucci, W. S., Sackner-Bernstein, J. D., Liang, C.-s., Goldscher, D. A., Freeman, I., Kukin, M. L., Kinhal, V., Udelson, J. E., Klapholz, M., Gottlieb, S. S., Pearle, D., Cody, R. J., Gregory, J. J., Kantrowitz, N. E., LeJemtel, T. H., Young, S. T., Lukas, M. A., Shusterman, N. H. (1996). Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure: The PRECISE Trial. Circulation 94: 2793-2799 [Abstract] [Full Text]  
• Garg, R., Yusuf, S., the Collaborative Group on ACE Inhibitor Trials, , Bussmann, W. D., Sleight, P., Uprichard, A., Massie, B., McGrath, B., Nilsson, B., Pitt, B., Magnani, B., Maskin, C., Ambrosioni, E., Rucinska, E., Kleber, F. X., Jennings, G., Tognoni, G., Drexler, H., Cleland, J. G. F., Franciosa, J. A., Remes, J., Swedberg, K., Swedberg, K., Dickstein, K., Maass, L., Pfeffer, M., Creager, M. A., Gordon, M., Joy, M., Sharpe, N., Sleight, P., Desche, P., McGarry, R., Collins, R., Chrysant, S. G., Cicchetti, V., Bussmann, W. D. (1995). Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure. JAMA 273: 1450-1456 [Abstract]  
• Baker, D. W., Konstam, M. A., Bottorff, M., Pitt, B. (1994). Management of Heart Failure: I. Pharmacologic Treatment. JAMA 272: 1361-1366 [Abstract]  
• Marantz, P. R., Alderman, M. H., Tobin, J. N. (1988). Diagnostic Heterogeneity in Clinical Trials for Congestive Heart Failure. ANN INTERN MED 109: 55-61 [Abstract]  
• Mulrow, C. D., Mulrow, J. P., Linn, W. D., Aguilar, C., Ramirez, G. (1988). Relative Efficacy of Vasodilator Therapy in Chronic Congestive Heart Failure: Implications of Randomized Trials. JAMA 259: 3422-3426 [Abstract]